Xeltis wants to make life better for patients with heart valve disease. At Xeltis, we are leveraging breakthrough science to transform heart valve treatment – making the seemingly impossible happen. We enable the patient’s own body to naturally restore a new heart valve through a therapeutic approach called Endogenous Tissue Restoration (ETR). We aim to overcome the limitations of current artificial heart valves: to improve the lives of hundreds of thousands of patients requiring heart valve replacements, while reducing overall healthcare systems costs. We are striving to bring our restorative approach in heart valve therapy to clinicians and patients throughout the world. We are truly motivated by helping patients who need a new heart valve to live a better life, soon.